At least four Stryker Rejuvenate hip lawsuits have been settled as a result of early mediation efforts. Stryker’s parent company, Howmedica Osteonics Corp., currently faces around 1,000 complaints regarding issues with their Rejuvenate and ABG II hip implants, but that number is expected to grow. While... Read More
Takeda Pharmaceuticals and Eli Lilly are facing a new Actos bladder cancer lawsuit brought by a New Jersey couple who argue the defendants manufactured and distributed a dangerous drug. The claim was filed on November 27, 2013 by Alexander Vacula and his wife, Alice. The... Read More
A recent scheduling order issued by U.S. District Judge Robert L. Miller has outlined the selection process for bellwether cases in the Re: Biomet M2A Magnum Hip Implant Products Liability Litigation. The order, handed down on December 10, indicates that the first Biomet hip lawsuit... Read More
The U.S. District Judge presiding over the group of Zoloft birth defect lawsuits currently pending under multidistrict litigation in the Eastern District of Pennsylvania has outlined the process of narrowing down the lawsuits eligible for the first bellwether trials. More than 420 product liability cases... Read More
A Texas resident has filed a Yaz stroke lawsuit in federal court in New Jersey alleging Bayer Pharmaceutical’s birth control pills, Yaz and Yasmin, are responsible for the stroke she suffered in November 2011. Denise Jackson filed the claim in November 2013 in the U.S.... Read More
The U.S. Judicial Panel on Multidistrict Litigation (JPML) issued a Notice of Hearing Session indicating the panel will reconsider the pretrial coordination of 56 Lipitor diabetes lawsuits pending in federal courts throughout the nation. The product liability complaints were brought by women who allege the... Read More
Five plaintiffs have filed an Infuse bone graft lawsuit in California Superior Court, adding to the growing litigation against Infuse manufacturer Medtronic. All five of these plaintiffs allege they received the Infuse device off-label and have since suffered serious complications due to bone overgrowth, neuropathy... Read More
